DellingerRP. Clinical trials in adult respiratory distress syndrome. New Horiz1993;1(4):584–592.
6.
MontgomeryAB, StagerMA, CarricoCJ, HudsonLD. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis1985;132(3):485–489.
7.
HurdSS, LenfantCJM. Pulmonary research: what topics? what costs (editorial)?Am Rev Respir Dis1987;135(3):521–522.
8.
ButlerRN. Quality of life: can it be an endpoint? how can it be measured?Am J Clin Nutr1992;55(6, Suppl):1267S–1270S.
9.
AaronsonNK. Quality of life assessment in clinical trials: methodologic issues. Controlled Clin Trials1989;10(4, Suppl):195S–208S.
10.
ChangRWS, BealeR, SmithiesM, BihariD.A preliminary cost-performance evaluation of HA-1A (cenotoxin) with an addendum on its demise. Clinical Intensive Care1993;4:208–216.
11.
Vandenbroucke-GraulsCM, VandenbrouckeJP. Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit. Lancet1991;338(8771):859–862.
12.
SchatzkinA, FreedmanLS, SchiffmanMH, DawseySM. Validation of intermediate end points in cancer research. J Natl Cancer Inst1990;82(22):1746–1752.
13.
BoisselJP, ColletJP, MoleurP, HaughM.Surrogate endpoints: a basis for a rational approach. Eur J Clin Pharmacol1992;43(3): 235–244.
14.
TüysüzB, OzluI, AjiDV, ErginelA.Prognostic factors in meningo- coccal disease and a new scoring system. Acta Pediatr1193;82(12):1053–1056.
15.
LemeshowS, Le GallJR. Modeling the severity of illness of ICU patients: A systems update. JAMA1994;272(13):1049–1055.
16.
DreyfussD, BassetG, SolerP, SaumonG.Intermittent positive-pres- sure hyperventilation with high inflation pressures produces pulmonary microvascular injury in rats. Am Rev Respir Dis1985;132(4):880–884.
17.
DreyfussD, SaumonG.Lung inflation: physiologic and anatomic alterations leading to pulmonary edema. In: ZapolWM, LemaireF, editors. Adult respiratory distress syndrome. New York: Marcel Dekker; 1991:433–449.
18.
HicklingKG, HendersonSJ. Low mortality associated with low vol- ume pressure limited ventilation with permissive hypercapnia. Intensive Care Med1990;16(6):372–377.
19.
KnausWA, SunX, HakimRB, WagnerDP. Evaluation of definitions for adult respiratory distress syndrome. Am J Respir Crit Care Med1994;150(2):311–317.
20.
KnausWA, HarrellFE, FisherCJJr, WagnerDP, OpalSM, SadoffJC, DraperEA, . The clinical evaluation of new drugs for sep- sis. A prospective study design based on survival analysis. JAMA1993;270(10):1233–1241.
21.
FisherCJJr, DhainautJFA, OpalSM, PribbleJP, BalkRA, SlotmanGJ, . Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a ran- domized, double-blind, placebo-controlled trial. Phase III. JAMA1994;271(23):1836–1843.
22.
TangDI, GellerNL, PocockSA. On the design and analysis of ran- domized clinical trials with multiple endpoints. Biometrics1993;49(1):23–30.
23.
O'BrienPC. Procedures for comparing samples with multiple end- points. Biometrics1994;40:1079–1087.
24.
FriedmanLM, FurbergCD, DeMetsDL. Fundamentals of clinical trials, 2nd ed. St Louis: Mosby Yearbook1985:256.
25.
WoolsonRF. Statistical methods for the analysis of biodmedical data. New York: John Wiley & Sons, 1987:327–337.
SittigDF, GardnerRM, MorrisAH, WallaceCJ. Clinical evaluation of computer-based respiratory care algorithms. Int J Clin Monit Comput1990;7(3):177–185.
28.
CookDJ, JaeschkeR, GuyattGH, Journal Club of the Hamilton Regional Care Group. Critical appraisal of therapeutic interventions in the intensive care unit: human monoclonal antibody treatment in sep- sis. J Intensive Care Med1992;7:275–282.
29.
DonahoeM, RogersRM. An anecdote is an anecdote is an anecdote but a clinical trial is data (letter). Am J Respir Crit Care Med1994;149(2, Part):293–294.
30.
RubenfeldGD. Study design: statistical and methodologic consid- erations. Respir Care1995;40(9):980–986.